IL33 and atherosclerosis: Although described in a murine atherosclerosis model as an atheroprotective cytokine [13], extracellular IL-33 induces proinflammatory, prothrombotic, and proangiogenic activation of human endothelial cells [5,14,15] and stimulates the release of procoagulant microvesicles from human monocytes [16].